CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Relapsed Pediatric ALL · Hematopoietic Cell Transplantation · Hematologic Malignancy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Swati Naik, MBBS) · referralinfo@stjude.org · 888-226-4343
Contact: Principal Investigator (Swati Naik, MBBS)

Study leads

Swati Naik, MBBS
Principal Investigator
St. Jude Children's Research Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Hematologic Malignancy · AML · ALL

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Orange, United States

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Hematologic Malignancy · Leukemia · Lymphoma

Abroad (travel likely)Recruiting

Aurora, United States · Cincinnati, United States

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia, Refractory · Pediatric ALL

Abroad (travel likely)RecruitingPHASE1

Memphis, United States

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Acute Lymphoblastic Leukemia · Relapsed Pediatric ALL · Refractory Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China